Cell and Gene Therapy Services
Cell & Gene Therapies (CGT)
We help you characterize complex cell and gene therapies, including CAR-T products, viral vectors, LNPs, so you can understand potency, persistence, biodistribution, and immune response before moving forward.
Cell Therapy (e.g., CAR-T, NK cells):
Deep Phenotyping:
We build extensive flow cytometry panels to characterize T-cell subsets and exhaustion markers after manufacturing.
Serial Killing Assays:
We run prolonged co-culture assays with tumor spheroids to measure sustained cytotoxicity over several days.
Gene Delivery Systems (Viral & Non-Viral):
Transduction/Transfection Efficiency:
We evaluate how effectively your vectors, including AAVs, LNPs, or polyplexes, deliver their payload to target cells.
Vector Immunogenicity:
We assess whether your delivery vehicle triggers unwanted innate immune responses, including anti-drug antibodies or Toll-like receptor activation.
Biodistribution Studies:
We track where your non-viral vectors localize systemically using sensitive molecular readouts such as digital PCR.
